Find a Clinical Trial

Physicians

Learn how we help support and foster independent practices.

Visit Site

Patients

Learn how we help make patient care our number one priority.

Visit Site

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Texas Oncology - Rockwall

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Rockwall

(I3Y-MC-JPCF) monarchE: A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

  • Details

ClinicalTrials.gov ID: NCT03155997
Diagnosis Type: NA
USOR Number: 17082

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Rockwall

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Rockwall

POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study (A5481082)

  • Details

ClinicalTrials.gov ID: NCT03280303
Diagnosis Type: NA
USOR Number: 16128

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Rockwall

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Rockwall

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Rockwall

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Rockwall

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Rockwall

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Rockwall

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Rockwall

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations(FIGHT-201)(INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Rockwall

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations(FIGHT-201)(INCB 54828-201)

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

3144 Horizon Rd, Suite 110
Rockwall, Texas 75032
293.39 mi. away
P: (972) 771-3322

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Dallas

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Graft vs Host Disease

Clinical Trial at: Texas Oncology - Dallas

INCB 39110-309: A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)

  • Details

ClinicalTrials.gov ID: NCT03584516
Diagnosis Type: NA
USOR Number: 18130

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Dallas

Pevonedistat-3001: A Phase 3, Randomized, Controlled, Open-label, Clinical Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Low-Blast Acute Myelogenous Leukemia

  • Details

ClinicalTrials.gov ID: NCT03268954
Diagnosis Type: NA
USOR Number: 17153

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Hematologic

Clinical Trial at: Texas Oncology - Dallas

INCB 39110-309: A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)

  • Details

ClinicalTrials.gov ID: NCT03584516
Diagnosis Type: NA
USOR Number: 18130

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
294.70 mi. away
P: (972) 566-7790

More Details View Practice Page

Pages

Patient Sub Menu

Patients